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Cloning of mouse c-ros renal eDNA, its role in development and
relationship to extracellular matrix glycoproteins. Renal organogenesis
ensues following reciprocal interactions between the uninduced meta-
nephric mesenchyme and the ureteric bud. Conceivably, the presence of
ligands or growth factors on a given cell type, and expression of receptors,
including receptor proto-oncogenes, on the other cell type of different
lineage would facilitate such epithelial-mesenchymal interactions. During
these interactions, other macromolecules, such as extracellular matrix
(ECM) proteins, present at the epithelial-mesenchyma! surface, also play
a role in the kidney morphogenesis. In this study the proto-oncogene,
c-ros, was cloned and sequenced; its role in the metanephric development
was examined, and correlated with the changes in the expression of ECM
proteins. The mouse c-ros renal eDNA, belonging to phosphotyrosine
kinase (PTK) receptor family, had a translation product of 2340 amino
acids. The extracellular domain had 32 N-linked glycosylation sites and 30
cysteine residues. The transmembrane segment had a hydrophobicity
approaching - 3.5. Multiple phosphorylation sites, typical of a PTK
catalytic unit, were present in the cytoplasmic domain. The 3' noncoding
region did not contain any A(U)A mRNA instability motifs. The c-ros
mRNA was highly expressed on the ureteric bud branches and their tips
and on the developing glomeruli. Competitive RT-PCR analyses revealed
the c-ros expression was the highest at 13th day of gestation, and it
declined to very low levels during the neonatal period. Exposure of
metanephric kidneys to c-ros antisense-oligonucleotide, derived from the
PTK domain, caused dysmorphogenesis of the kidney and loss of c-ros
expression on the ureteric bud branches. Concomitant with the reduced
c-ros gene expression, a decreased expression of ECM glycoproteins, in
particular the proteoglycans, was observed. These findings suggest that the
c-ros plays a role in the metanephric development, and its effects may be
modulated by the ECM macromolecules present at the epithelial-mesen-
chymal interface.
During embryonic life, the organogenesis proceeds by progres-
sive differentiation of progenitor pluripotent cells and rapid
proliferation of the differentiated cells. These events constitute a
series of complex coordinated processes which lead to the forma-
tion of a properly sculptured critical tissue mass, and are followed
by terminal cell differentiation and organogerlesis [1]. They are
modulated by various ligand-receptor cellular interactions, and
are regulated by a wide variety of macromolecules, such as
extracellular matrix (ECM) proteins [2, 3], integrins [4, 5], growth
factors [6, 7], and their receptors [8, 9], transcription factors [10]
and proto-oncogenes [11]. The latter are implicated in an aberrant
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growth of neoplastic cells, and the introduction of proto-onco-
genes into normal cells results in an accelerated growth [12, 131.
Apparently, it is these biological properties of proto-oncogenes
which led many investigators to study their role in various
growth-related processes such as embryogenesis. Furthermore,
their well-defined spatio-temporal expression in various embry-
onic tissues also suggest their relevance in early developmental
events. A large number of proto-oncogenes, including c-ros, have
been studied as to their relevance during embryogenesis and in
the morphogenesis of individual organ systems [14, 15].
The proto-oncogene c-ros was initially isolated from human
genomic DNA by hybridization with the v-ros sequence of UR2
sarcoma virus [16, 17]. The c-ros encodes a truncated tyrosine
kinase receptor, and is a transmembrane protein with a predicted
Mr 260 kDa prior to its post-translational modifications [18]. It
shares certain structural similarities in its catalytic cytoplasmic
domain with other receptors of protein tyrosine kinase family, for
example, insulin receptor [19], insulin-like growth factor-I recep-
tor [20, 21], and hepatocyte growth factor receptor (c-met) [22],
which are relevant in the renal organogenesis [19—26]. Upon
ligand interaction, the respective receptors transduce signals
across the plasmalemma, and activate various intracellular kinase-
dependent pathways, which eventually influence the nuclear
events and cell behavior [27, 28]. The c-ros has yet no well-
characterized ligand, but certain ligand-receptor interactions
deemed necessary to envision and assign its role in various
biological processes [29, 30].
Interestingly, the c-ros has a high degree of sequence homolgy,
both in the intra- and extracellular domains, to the gene product
of sevenless from Drosophila, and in fact, the c-ros and sevenless
are believed to be derived from a common evolutionary ancestor
[31, 32]. Since in Drosophila, the sevenless seems to be involved in
the cell-cell communication and signal transduction processes
affecting the differentiation and morphogenesis of the compound
eye [33], its vertebrate homologue, c-ros, may be expected to have
some role in mammalian development [34]. Moreover, its expres-
sion in the urogenital tract, intestine and lungs during mouse
embryogenesis indeed is suggestive of its relevance in organogen-
esis [31, 31.
In the kidney, the c-ros seems to be localized to the tips of
ureteric bud branches and developing glomeruli [34]. These tips
are the critical sites where epithelial-mesenchymal interactions
take place, and are enriched with ECM glycoproteins [35], which
are believed to regulate the morphogenesis of various organs.
Among the various ECM glycoproteins, the proteoglycans (PGs)
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are heavily concentrated at the tips of ureteric bud branches, and
have been shown to modulate metanephric development [36, 37].
Since, c-ros and ECM glycoproteins seem to co-localize in various
regions of the fetal kidneys, efforts were made in this study to
elucidate a role of c-ros, especially of its tyrosine kinase catalytic
domain, in metanephric development, and to establish its rela-
tionship to other putative morphogenetic modulators of organo-
genesis, that is, ECM glycoproteins.
Methods
Animals
ICR mice (Harlan Sprague Dawley, Inc., Indianapolis, IN,
USA) were used for paired male-female mating, and the appear-
ance of the vaginal plug was designated as day 0 of fetal gestation.
At days 13 to 19 of the gestation, embryonic kidneys were
aseptically harvested; in addition, kidneys were obtained from the
neonatal mice.
Construction of embryonic mouse kidney cDNA library
Total RNA from -—1,000 embryonic kidneys of 13-day-old
mouse was isolated by guanidinium isothiocyanate-CsC1 centrifu-
gation method [21, 38, 39]. Poly(A) RNA was selected by
oligo(dt)-cellulose chromatography. First-strand eDNA was syn-
thesized by using Moloney murine leukemia virus reverse tran-
scriptase (MMLV-RT, RNase H—) and oligo(dt)25d(G/C/A) as a
primer (Clontech, Palo Alto, CA, USA). Double-stranded cDNA
was prepared by RNase H-DNA polymerase I method for second-
strand synthesis [21, 39, 40]. After ligation of EcoR I-Not I-Sal I
adaptors and polynucleotide kinase phosphorylation, the double-
stranded eDNA was size-fractionated, and fragments < 500 bp
were removed by CHROMA SPIN"-1000 Column (Clontech).
The eDNA was ligated into EcoR I digested and dephosphory-
lated A ZAP II vector, and packaged using Gigapack II Gold
Packaging Extract (Stratagene, La Jolla, CA, USA). The pack-
aged ligation product was incubated with E. coli XL1-Blue MRF'
cells for plating and titration of the recombinant phage plaques
[21, 39].
Screening of library and isolation of eDNA clones
Initially, a polymerase chain reaction (PCR) product was
generated for screening the eDNA library. Total RNA from —100
newborn kidneys was extracted, poly(A) RNA selected and first
strand eDNA synthesized as described above. The eDNA was
used as the template in the PCR reaction mixture. The primers
were derived from nucleotide sequences conserved across species
(rat and human), and they were: 5'-CGGCGGTGTTTAAT-
GGGTCCTGC-3' (5788 to 5810 bp) and 5'-CCCACGCCTAG-
GATGTCTATAGCTGTGCC-3' (6260 to 6288 bp) [18, 31]. A
501 base pair (bp) PCR amplification product was generated, and
cloned into pCR' II vector (Invitrogen Cor., San Diego, CA). The
nucleotide sequence of PCR fragment had a high degree of
homolgy (—93%) to that reported for the rat c-ros gene with
GenBank accession # M35 106 [31]. The cloned PCR product was
amplified, and used as a probe (Fig. 1) for screening the cDNA
library. About 0.5 X 106 recombinants were screened with
[a-32P]dCTP-labeled PCR fragment. Nitrocellulose filter lifts
(Schleicher & Schuell, Keene, NH, USA), prehybridization and
hybridization conditions were chosen as previously described [21,
39]. Several clones were isolated, and purified by dilutional
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Fig. 1. Schematic drawing of mouse c-ros renal cDNA (clone #2), and its
fragments utilized for subcloning and sequencing. PCR amplified product,
indicated as PCR probe (—), was used for screening of the renal eDNA
library. The designations E and P represent EcoR I and Pst I sites; SE1
and SE2 are EcoR I-digested fragments; SPI-SP5 are Pst I-digested
fragments; EC is extracellular domain; PTK is protein tyrosine kinase
segment.
secondary and tertiary screenings. The clones containing cDNA
inserts which strongly hybridized with PCR product were pro-
cessed for further subcloning into pBluescript II KS(+) phagemid
(Stratagene).
Nucleotide sequence analyses of the cDNA clones
Ten clones were isolated, and the largest clone of — 7.5 kb
(clone #2) was utilized for further subcloning and nucleotide
sequence analyses (Fig. 1). Five other smaller overlapping clones
were sequenced as well. EcoR I digestion of the eDNA insert of
clone #2 generated three fragments of — 1.8, 0.5 and 6.0 kb,
which were designated as SE1, SE2 and SE3, respectively. The
digestion of SE3 with Pst I generated five fragments, and were
designated as SP1—5 (Fig. 1). These seven fragments (SE1—2 and
SPI—5) were subeloned into pBluescript H KS(+) phagemid using
XLI-Blue MRF' cells. For the rescuing of single-stranded DNA,
the transfected cells were grown in the presence of VCSM13
helper phage. The supernatants of the cultures were saved, and
the single-stranded DNA isolated by polyethylene glycol (PEG)
precipitation. After determining the sense or antisense orienta-
tion of various subclones, the nucleotide sequencing was per-
formed by the dideoxy chain-termination method [21, 39, 41],
followed by hydropathic [421 and sequence homology analyses
[43] using WISCONSIN PACKAGE Version 8.0.1-UNIX (Mad-
ison, WI, USA).
Expression studies by competitive PCR analyses
The c-ros gene expression was investigated at various stages of
embryonic development and during the neonatal period. The
method of competitive RT-PCR was chosen in order to circum-
vent the difficulties related to the minute amount of mRNA
available for Northern blot analysis from the embryonic kidneys
harvested at 13th day of gestation.
First, a "c-ros competitive plasmid DNA" was constructed by
ligating Pst I fragments SP3 and SP5, derived from subclone SE3,
into plasmid pBluescript. In doing so, the Pst I-5P4 fragment was
bypassed. The plasmid was propagated by using XL1-blue MRF'
I
— PCR probe
Ec I IPTKI I C-ROS1
Clone #2
SE1 E E PPPP
SE2 —
sP1
SP2 —SP3 —
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cells and multiple subclones were randomly selected. The plasmid
subclone with 5'—3' (SP3) to 5'—3' (SP5) orientations (deter-
mined by nucleotide sequence and restriction enzyme analyses)
was selected. It was then further propagated in XL1-blue MRF'
cells, and used as a "c-ros competitive plasmid DNA" in the
quantitative PCR analyses.
Next, the kidneys from fetuses or neonates were harvested 13,
17, 21 and 41 days post-conception. Total RNA was extracted
from the kidneys by the acid guanidinium isothiocyanate-phenol-
chloroform extraction method [37, 44]. Extracted RNA was
digested with RNase-free DNase (1 UIpJ) in the presence of
ribonuclease inhibitor (1 U/jtl) for one hour at 37°C. After
chloroform-phenol extraction, the RNA was reprecipitated with
ethanol in the presence of RNase-free glycogen (0.1 tg/tl).
About 50 sg of total RNA, isolated from each developmental
stage, was used for first strand cDNA synthesis, using MMLV
reverse trasricriptase (25 U/jd) and oligo(dt) as a primer [21, 37,
39]. The eDNA was ethanol precipitated, dried and suspended in
50 sl of deionized autoclaved water, and kept at —70°C till further
use.
Two 26- and 29-mer oligodeoxynuleotide (ODN) primers were
synthesized in sense (5'-.CCAGAGAAACCCTGTGCClTGGT-
TCC-3') and antisense (5'-CGCCTAGGATGTCTATAGCTGT-
GCC-3') orientations, and their sequences were derived from SP3
and SP5 subclones, respectively. The expected size of PCR
product, using these primers and the "cDNAs" from various
stages of kidney development would be — 939 bp, while the
expected PCR product size would be — 579 if the "c-ros compet-
itive plasmid DNA" is used in which subclone SP4 (—0.36 kb) had
been bypassed. Mouse 13-actin was used as an internal control, and
primers employed were as follows: 5'-GACGACATGGAGAA-
GATGTGG-3' and 5 '-GAGGATGCGGCAGTGGCCCAT-3'.
The expected PCR product size using these primers and various
kidney cDNAs as template would be — 461 bp [37]. A "f3-actin
competitive plasmid DNA" was also synthesized at the North-
western Biotech facility, and ligated into the EcoR I digested and
dephosphorylated pBluescript using EcoR I and GC clamp link-
ers. The nucleotide sequence of this plasmid insert is available in
GenEMBL data bank with accession # U17140. Using "13-actin
competitive plasmid DNA" and the primers, the expected size of
the PCR product would be — 224 bp.
The PCR reaction mixture, for "non-competitive" amplification
of c-ros products, included 100 LM dNTPs, 1 j.M primers, 0.5 to 10
tl embryonic kidney cDNA, 2.5 units of AmpliTaq DNA poly-
merase and 10 tl of lOx PCR-enzyme buffer in a total volume of
100 sl. The reaction was carried out in a DNA Thermal Cycler
(Perkiri Elmer Cetus Inc., Norwalk, CT, USA) as follows: dena-
turation for one minute at 95°C, annealing for one minute at 55°C
and extension for two minutes at 72°C. A total of 30 thermal cycles
were employed. The c-ros PCR products were analyzed by 2%
agarose gel electrophoresis, and photographed using an instant
positive/negative film (Polaroid # 665). The negatives were
analyzed by a scanning densitometer (Hoefer Scientific Ins., San
Francisco, CA, USA), and readings were logarithmically plotted.
A linear increase in the amplification of PCR products was
observed when 1 to 8 pi of cDNA were used. In addition, the
identity of the PCR products was ascertained by Southern blot
hybridization with [a-32PIdCTP-labeled cDNA c-ros clones, and
confirmed by nucleotide sequence analyses.
After confirming the nucleotide sequence of c-ros products,
competitive PCR analyses on various kidney cDNAs were per-
formed. Initially, a fixed amount (2.0 pl) of "cDNA" from the
13-day-old mouse kidneys was co-amplified with serial logarithmic
dilutions of "competitive plasmid DNA" of either c-ros or 13-actin,
using the same reaction conditions as described above. After
densitometric recordings of various PCR products, ratios between
the amplified "c-ros eDNA" and "c-ros competitive plasmid
DNA" were calculated. The ratios were further adjusted for the
bp size of each eDNA, and plotted on a logarithmic scale against
serial dilutions of the "c-ros competitive plasmid DNA". Similarly,
the ratios were plotted for the amplified "f3-actin eDNA" and
"-actin competitive plasmid DNA". The concentrations of the
"competitive plasmid DNAs" of c-ros and /3-actin were selected
where comparable ratios between the two groups were observed.
Thus, fixed amounts of "eDNA" and "competitive plasmid DNA"
were used, and kept constant throughtout all the subsequent
experiments where the expression of c-ros and f3-actin was deter-
mined at various developmental stages of the kidney.
Expression studies by in situ hybridization
The hybridization studies were performed to ascertain the
localization of c-ros message in epithelial versus mesenchymal
compartments of mouse embryonic kidney. First, an antisense
oligodeoxynucleotide (ODN) probe was prepared. The nucleotide
sequence of the 29-mer ODN was the same as that of the
antisense primer used for competitive PCR amplification and
analyses, that is, 5'-CCCACGCCTAGGATGTCTATAGCTGT-
GCC-3', which is derived from the phosphotyrosine kinase do-
main of the c-ros. It was end-labeled with [35S]dATP using
polynucleotide kinase reaction (New England Biolabs, Beverly,
MA, USA). The technical aspects of in situ hybridization have
been detailed previously [21]. Briefly, the fetal kidneys were fixed
in 4% paraformaldehyde in PBS buffer, pH 7.0, for 12 hours at
4'C, dehydrated in graded series of ethanol, and embedded in
paraffin. Three micrometer-thick sections were prepared, and
mounted on acid-treated, ethanol-cleaned and poly-L-lysine-
coated slides. The sections were de-paraffinized, hydrated, depro-
teinated, briefly treated with triethanolamine-acetic anhydride,
rehydrated, and hybridized with the radio-labeled antisense-ODN
probe (Tm 35°C) in the presence of formamide, dextran sulfate
and Denhardt's solution at 37°C for 60 minutes under RNase-free
conditions. Hybridization was followed by washing of the slides at
40°C (Tm 35°C + 5°C) with lx SSC (sodium chloride and sodium
citrate), and dehydration in a graded series of ethanol in 0.6 M
ammonium acetate. The slides were coated with ILFORD KS
emulsion (Polysciences, Warrington, PA, USA), and developed
after one to three weeks of exposure [21, 36, 37].
Antisense experiments
The role of c-ros in renal development was investigated in a
metanephric culture system, in which the embryonic kidneys,
harvested at day 13 of gestation, are placed on the top of a
nucleopore filter and maintained for five to seven days. The
details of the metanephric culture system have been described
previously [45, 46]. The antisense-ODN, used for the in situ
hybridization, was phosphorothioated, and included in the culture
medium at concentrations from 0 to 1.0 tM. Upto a concentration
of 1.0 jiM the ODN retained its specificity with no discernible
cytotoxic effects [21, 37]. The specificity for the target nucleotide
sequences was established by S nuclease protection assays as
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desribed previously [37, 47]. Moreover, the antisense-ODN did
not display significant homology with other known nucleotide
sequences available in GenEMBL bank data using the FASTA
program. Additional two controls (nonsense) 31-mer phosphoro-
thioated-ODNs with nucleotide sequences as 5'-TAATGATAG-
TAATGATAGTAATGATAGTAAT-3' and 5 '-GATCGATC-
GATCGATCGATCGATCGATCGAT-3' were prepared.
The effect of nonsense or antisense-ODN on the c-ros mRNA
gene expression was investigated by competitive PCR methods as
described above. Briefly, the embryonic kidneys were either
exposed to antisense- or nonsense-ODNs in metanephric culture
for 18 to 24 hours. The RNAs were extracted, cDNAs prepared,
and used as templates for competitive PCR analyses. 13-actin was
used as an internal control as indicated earlier. In addition, the
fetal kidneys were exposed to various ODNs for one to six days,
and the explants were processed for morphological studies. The
sections from the midplane of the embryonic kidneys with a
maximum number of ureteric bud iterations and including both
the poles and the hilus were evaluated. For each variable, 20 to 30
metanephric explants were examined. Some of the explants were
also processed for in situ hybridization.
Expression of major extracellular matrix (ECM) glycoproteins
Since the ECM proteins are believed to be involved in the
morphogenesis of various organ systems during embryonic life,
the status of ECM glycoproteins was examined following disrup-
tion of c-ros by the antisense-ODNs. Embryonic kidneys, main-
tained in the metanephric culture, were exposed to c-ros anti-
sense-ODN for 24 to 48 hours, washed three times with the cold
medium, and processed for expression studies, utilizing competi-
tive RT-PCR as described above. The ECM glycoproteins studied
were perlecan, laminin and type-IV collagen. A competitive
plasmid DNA for each ECM glycoprotein and for /3-actin, was
constructed at Northwestern Biotech facility and purified by high
performance liquid chromatography, and each was ligated into
pBluescript KS( +) phagemid. The plasmid insert DNA nude-
otide sequence was available under the previously described
GenEMBL accession number # U17140. The expected size of
PCR products for perlecan, laminin, type-IV collagen and
/3-actin were also included in the GenEMBL data. The RT-
PCR procedures to assess the gene expression of ECM proteins
are described above.
In separate experiments, the embryonic kidneys exposed to
nonsense- and antisense-ODNs were radiolabeled either with
[35S]sulfate or [35S]methionine. The radiolabeled kidneys were
processed for light- and electron microscopic autoradiographic,
and immunoprecipitation studies. The antibodies employed for
immunoprecipitation experiments included anti-type IV collagen,
-laminin (Gibco, Grand Island, NY, USA) and -heparan sulfate-
proteoglycan (HS-PG) [21, 37, 47]. The methods for immunopre-
cipitation and for tissue autoradiography have been extensively
detailed previously [21, 37, 47].
Results
Cloning, sequencing and characterization of embryonic mouse
kidney c-ros cDNA
The strategy for cloning, subcloning and sequencing of c-ros
renal cDNA is depicted in Figure 1. Eight subclones from the
7.427 kb clone were generated and characterized as described in
the Methods section. The sequence data of embryonic mouse
renal c-ros DNA were available in the GenEMBL data bank with
accession # U15443. The open reading frame with an ATG codon
extended from bp 288 to bp 7307, and the deduced translational
product consisted of 2340 amino acids (Fig. 2). Similar to the rat
c-ros renal cDNA, the predicted translated product had three
domains, that is, extracellular, transmembrane, and cytoplasmic,
which consisted of 1849, 25 and 466 amino acid residues, respec-
tively. The phosphotyrosine kinase (PTK) region was located in
the cytoplasmic domain and consisted of 26 amino acids (Fig. 1).
The PTK region had 72% and 91% homology with that reported
for chicken and rat c-ros, respectively. A total of 32 potential
N-linked glycosylation sites, that is, with a sequence of N-X-T/S
(asterisks), and about 30 cysteine amino residues (inverted trian-
gles) were identified in the extracellular domain (Fig. 2). The
intracellular domain had one N-linked glycosylation site, and
contained about 12 cysteine residues. A G-X-G-X-X-G stretch of
amino acids containing the ATP binding catalytic site and lysine
was present in the intracellular domain (closed circles). Also, a
stretch containing multiple polyadenylation sites was found in the
non-coding region at the 3' end of the c-ros. The hydropathic
analyses showed two hydrophobic domains, stretching from 2 to
41 and 1850 to 1874 amino acid residues, and are indicated by
quadrangles (Fig. 2). In both the domains the hydrophobicity
values approached 3.5. (Fig. 3), and they were devoid of glycosy-
lation sites. The first hydrophobic domain supposedly serves as
the signal peptide, while the second domain corresponds to the
transmembrane segment of the c-ros glycoprotein. In addition to
this full-length cDNA clone (clone # 2), five other overlapping
clones were sequenced, and no alternate splice variants were
detected.
Expression of c-ros in metanephric development
Initially, the conditions of RT-PCR for achieving linear ampli-
fication of the c-ros cDNA were established. The non-competitive
PCR analyses indicated a linear amplification of the c-ros prod-
ucts when 1 to 8 jsl of cDNA from from 13-day-old mouse kidney
was used. In the quantitative PCR analyses, a constant amount of
cDNA (2.0 pl) was used with serial dilutions (10—' to 10—8) of
competitive plasmid DNA (1.0 pi), having an initial concentration
of 500 ngIsl. A linear increase in the amplification of c-ros cDNA
with serial logarithmic dilution of the competitive DNA between
the range of 10_i to 10 was observed. Also, the linearity was
maintained when the "ratio" of c-ros cDNA to competitive
plasmid was plotted against serial dilutions of the plasmid DNA
Fig. 2. Nucleotide and deduced amino acid sequence of full-length mouse c-ros renal cDNA. Symbols are: (•) the signal peptide and transmembrane
hydrophobic domains; (*) potential N-linked glycosylation sites; (V) cysteine residues; (•) the consensus sequence for ATP binding catalytic site
(G-X-G-X-X-G).
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I K V K V I S Q U I I S I T 0 V F S N I 525
cttatgaagtcaaagtttattcccaqgacatccttqaaatcactcaagttttctcgaaca 2160
V5 0 T H L K I P 5 L Q S S T K I P F S C 645
taagcgggaccatgcttaagttacccgaactgcagagttctacaaagtatccgttctcgt 2220
ft A S S P K 0 P 0 P 0 S A P 5 V 0 T T L 665
gtagagcaagttctcctaaaggcccaggcccagggtcagcaaoatcagtgggtaccacct 2280
V P A T E L L F I H A V K E 0 0 I W S K 685
tggtaccagctactgaattattattcatcatggctgtgaaagaagatgggctctqgagca 2340
V *
P 1 C S F 0 P 0 5 F L S 5 0 V 0 N V S 0 705
aaccactctgtagttttggtccaggagaattcctgtcctctgatgtaggaaacgtgtcag 2400
H0WINNS LYISDTKONVYVft72S
atatggattggtacaacaacagcctctactacagtgacaoaaaaggcaacgtttatgtgc 2460
PLNGHD I SENIHIP S 1V0A0745
ggcctctgaatgggatggatatctcagagaattatcacatacccagcattgtaggagctg 2520
A L A F S N L C N F I I N A 0 K T I V I 765
gggctttggcctttgaatqgctgggtcactttctctactggpctgggaagacatatgtga 2580
QftQ SVLT ONTO TVTHVKLLV785
tccaaaggcagtctgtgttgacgggacacacggacattgtgactcatgtgaagctgttgg 2640
ND HAV0 S V 001 LI W T T LI S V805
tgaatgacatggctgtggattcagttggtggctatctctattggacaacactctactcap 2700
S S T ft L N 0 S 5 5 L V L 0 A 0 P W L 5 825
ttgaaagcaccagactcaatggagaaagttctcttgtactacaggctcagccctggctct 2760
GKKVVAL T L DL SOC LI 1WLV845
ctggaaaaaaggttgttgctctaacactapacctcagtgatgggctcctgtattggctqg 2820
VO 0 N 0 C I H I I T A V L ft 0 N S 0 0 0865
tgcaggacaatcagtgtattcatctgtacacagctgttcttcgaggatgqagtgqtgggg 2880
A TI T S FAAN ST SEISO NALH88S
atgctaccatcacagagtttgcagcctggagtacttotgaaatctcccagaatgctctga 2940
1 1 5 0 ft L F W I N 0 F ft I I T A Q S I 905
tgtactacagtggtagactcttctggatcaatggatttaggatcattacagcacaggaaa 3000
O 0 ft T S V S V S K P A K F N Q F T I I 925
taggtcagagaaccagtgtgtctgtttcggagccagcgaaattcaatcagttcacaatta 3060
O 1 5 L K P L P 0 N F S S T P K V I P 0 945
tacagacatctctcaaqcctctgccaggaaacttttcctctactcccaaggttatcccag 3120
P V QESSF ft I EON T SSF 01 LW965
atoctgttcaggagtcttoatttcgaattgaaggacacacttcaaqtttccaaatcctgt 3180
N E P P A V U W 0 I V F I S V K F S T N 996
ggaatgagccccctgcggtggactggggcatcgttttctacagtgtggaatttagcactc 3240
S K F L I I 5 Q Q S L P I F T V 5 0 L 5 1005
attocaagttcctgattattgaacaacagtctttacctatttttactgtggaaggactgg 3300
PIT LFNL SVT PIT IWOKO QK1025
agccctataccttatttaatctttctgtcactccttatacctactqpggaaagggccaaa 3360
T S L SF ftAPE SVP S APEN P ft 11045
aaacatctctatcatttcgtgcacctgaatcagttccatcagcaccagaaaaccccagaa 3420
F I L S ft 0 ft I T K K N K V V V S F ft W1065
tatttatattgtcaagaggaaqatacaccaagaagaatgaagttgtggtagagttcagot 3480
0 K P K N K N 0 V I T K F S I F I H I F 1095
gggataaacctaagcatgaaaatggagtgotaaccaaatttgaaatcttctatcacatat 3540
K 0 5 0 I N ft S T 5 0 N H S A S V I P P 1105
ttaaacaaagtqqcacaaatagatcaactgaagactggatgtctgccagtgttatacccc 3600
VHS F OLE AV S P KIT VA FQ Vft1125
cagtgatgtcttttcaacttgaggctgtgagtcctgagtatactgttgccttccaggtta 3660
V FT 5KG POP F SD IVH S KT SE114S
gagtcttcacatccaaagggcoagggccattttctgatatagtgatgtctaaaacatcag 3720
VIKP CPIL IS LLGNKIVFLDH1165
aaatcaagccatgtccgtatctcatatctcttctcgqcaataagatogtgtttotagaca 3780
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D Q N QVLWT F S LEG DV ST VG 11185
tggatcaaaatcaagttttgtggacattttccctggagggagacgtcagcacagtggggt 3840
T T 0 0 E H G I F A Q C 0 T L F L L N L 1205
acacaacagacgatgaaatggggtatttcgctcaaggagacacgctcttccttctgaatt 3990
KNNS $ SKLFQDALVSD 1KV11225
tqcgtaatcattcca4ttccaagcttttccaggatgcactqgtttctgacattagagtta 3960
V *
A V 0 W I A K N L C F A L K A S Q N C T 1245
ttgctgttgattggattgcaaggcacctctgctttgctctgaaagcatcacaaaacggaa 4020
V
0 I F N V 0 L E H K V K S P K E V K T C 1265
caoagatattcaatgttgaccttgaacacaaggtgaaatcccccagggaggtgaagactt 4080
KANT P 11SF S TYPLL SKLYW1285
gcaaagcacatacaacaataatttctttctctacatatcccctcttgagtcgcttgtatt 4140V'
T E V S 0 L C N Q H F I C N I S N H T 5 1305
ggacagaagtttcagatctgggccatcagatgttctactgcaatattagcaatcacacct 4200V V*QNVL OP KA SN QH GK SQ C SC N1325
cgcaacatgttctacaacccaaggcttcaaaccaacatggaaggagtcaatgttcttgta 4260
V T E S E L S G A H T V 0 T S D P 0 K P 1345
atgtgacagaatctgagttaagtggggcaatgactgtggatacctctqacccagacagac 4320
V V
W T I F T K K Q E T W A H 0 L E C C Q C 1365
catggatatactttaccaaaaggcaagagatctgggccatggatctggaaggatgtcagt 4380
WKVTHLPT IPCKKII SLTVD1485
gttggaaagtcatcatgttacctactatccctggaaaaagaatcattagcttaacagtgg 4440
GE F 11W IHKT ED DAQ 110 AK1405
atggggagtttatatattggatcatgaaaacaaaggatgatgcccaaatttatcaagcaa 4500
KG S GA T L S QVKA S K SEN I LA1425
agaagggaagcggggccatcCTTTCCCAACTCAACCCCTCCPsCCACTAACCAtatcttgg 4560
IS FKLQPFPDEAI L S LASDH1445
cttacagtttccgtctgcagccttttccagataaagcatatctgtctctagcttcagata 4620
VEAT ILYATNT SIT LKLPPV1465
tggtagaagcaactatattatatgccaccaacaccagcctcacactcaaattacctccag 4680
K T N L T W H C I T N P T S T I L T I I 1485
tcaagacaaacctcacgtggcatggaattacccaccccacgtcaacatacctgatttact 4740
I KANKAN SS 0 KKHKHL ES Q E1505
atataaaagctaatagggcaaacagctctgacaggagacacaaaatgctggaatcacagg 4800
NVAK lEG LOP F SHY HI Q 1AV1525
agaatgtagcccggattgaaggtctgcagccattttcaatgtacatgattcagatagctg 4860
ENYY SEP LEHLPLGKKFKDK1S4S
tgaagaactattattcagagcctttagaacatttacctcttggaaagagattcaaggaca 4920
V
P K S C V P C A V C N I N A T V L 5 0 T 1565
aaactaaaagtggagtgcctggggcagtttgtcatatcaacgcaactgtgttgtcggaca 4980
S LHVFWTESHKPNCPKE SVA1S85
coagtctccatgtattctggacagaatcccataagccaaacggaccaaaagagtcagtcg 5040
I SWLH SD LAP I PET P L K 0 GE1605
ctatcagctggttgatgtcagatctggctcccattcctgagactcctctaagacagggtg 5100
FP SAKLSLL TTKL S CCQLYV1625
aatttccaagtgccaagctttctctgctcatcactaaactatctggtggacagctctatg 5160
V V
H K V L A C H P E E H W C T K S H P V 5 1645
tgatgaaggttctggcgtgccaccctgaggaaatgtggtgtactgagagtcatcctgtca 5220
VNHFDT PEEP SALVPENT S 11665
gtgtcaacatgtttgacacaccagagaaaccctctgccttggttccagagaacaotagtc 5280
0 L 0 K K A K S N V N I T C F W F E 1 0 1695
tgcagttagaccggaaCgctcgatcaaacgttaacctcaccGGattttggtttgaactcc 5340
V
K W K I N E F I N V K A S C 5 Q C P V 1 1705
agaagtggaaatataatgagttttaccatgtcaaagcttcatgcagccaaggtccagttt 5400VVC NT T DL QP IT SIN I KVVVV1725
attctgtaacatcacagatctaaaaccttacacctcctataacattcgagtggtqgtgg 5460
ITT GE N SSS T P ES F KT KACV1745
tctatacgacaggagaaaatagctoothcattccagagagtttcaagaoaaaagccggag 5520
P SKPCIPKLLECSKN S 1QWE1765
tcccaagcaaaccaggtattcctaaattactagaagggagtaaaaattccatccagtggg 5580
at
K A E 0 N C S K L H I I S I K V K K C T 1785
aaaaagctgaagataatgggagcagattgatgtactactcccttgaggtcagaaaaggca 5640
• a * V
S N 0 $ Q N Q S S K W K V V F N C S C $ 1805
tttcaaatgactcacagaaccagagttcaaggtggaaggtggtgtttaatgggtcCtgCa 5700
VS ICTWKSKNLKCT FQFKAVA1825
gtagcatttgcacatggagatcaaaaaacctaaaaggaacatttcagttcagagcagttg 5760
ANE TCLCEISEI SED TT LVEX84S
ctgcaaatqaaattggacttggagaatatagtgaaatcagtgaagacattacattagtgg 5820
••fl••*••+•+•+•••**•••••••$t*••t••••••DCVWITET SF lIT IIVCIFLX865
aagatggtgtttggataacagaaacaagttttatacttactatcatagttgggatatttc 5880
+,.,,t+.......,......,...
V A T V P L T F V W N K S L K S N K A 5 1885
tggttgctacagtcccactgacctttgtctggcatagaaGcttqaaaagtcacaaagctt 5940
K K C I S V 1 $ 0 N 0 K E L A E I K C L 1905
ccaaggaaggcctctcggttctcagcgacaacgacaaagagttggCtgagcttcgaggtC 6000
AACVCIANACICINTVPTQE1925
tggcggctggagtgggactggccaatgcctgctacggcatacataatgttccaacccaag 6060
E IENIPAFPKEKL S LKLLLC194S
aagagattgaaaatcttoctgccttccctcgggagaagctgagcctgcgtcttttgttgg 6120
S C A F C K V I K C P A I 0 I L C V C S 1965
gaagtggagcttttggagaagtgtatgaaggcacagctatagacatcctaggcgtgggaa 6180
C E I K V A V K T L K K C S T 0 Q K K I 1985
gtggagaaatcaaagtggcagtgaagaccttgaagaaaggttCaaCagacCaggagaaga 6240
E F I K E A H L H S K F N N P N I L K 0 2005
ttgagttcctgaaggaggcgcacctgatgagcaagtttaatcaccccaacattctgaagc 6300
LCVCLLCEPQI I ILELHECC2O25
agctgggagtctgtctgttaggcgaaccccagtacattattctggaactgatggaagggg 6360
0 L L S I L K K A K C P P F N C P $ L T 2045
6420qagaccttctaagctatctgcgcaaagctcgggggacaacflttcatqgtccttcactca
LLDLVE LCVDI SKCCVY KL Q2065
ccttgcttgaccttgtagagctgtgtgtagatatttcaaaaggCtgcgtctacttggaCC 6480
N N F I N K 0 L A A K N C L V S V K 0 1 2085
;atgcacttcattcacagggatctggcagctcggaattgccttgtatcagtgaaagaCt 6540
T N P K V V K I C 0 F C L A K E I I K N 2105
acaccaatcctcgggtagtcaagattggtgactttggattggcaagagaaatctataaaa 6600
DII KKK CE CL L PAKWHA P K N2125
atqattattatagaaagagaggggaaggcctgcttcctgctCggtggatCgctcctgaaa 6660
LHD CI FT SQS DVW SF CI LVW2145
acttgatggacggaatcttcacttctcagtctgatgtatggtcctttggaattttggtgt 6720
El IT I CHOP I PANS N L DVL N2165
gggagattttaactctcggtcatcaaccttatccagcgcattccaaccttgatgttttaa 6780
I VQAG C KL E PP RN C POD LWN2185
actatgtgcaagcaggagggagactggagcctccaagaaattgtcotgatgatctgtgga 6840
L H $ 0 C N A 0 E P D Q K P P F N N I 0 2205
atttaatgtcccaatgctqggctcaagaacctgaccaaagacccactttccataacattc 6900
*NO 10 IF KNVF L N NV SN CC EA2225
aaaaccaacttcagttattcagaaatgttttcttaaacaatgtttCtcattgtggagaag 6960
A P T C C V I N K C F K C K 0 0 K H V P 2245
cagctcccaccggtggaqtcatcaacaaaggctttgaaggtgaagatgatgaaatggtca 7020
I N $ 0 D T H P V A I H E T K N 0 E C 12265
ctttgaactcagatgacacgatgccagttgccttgatggaaaccaagaaccaagaaggat 7080
NIHVVPQKC S QCECSIECPL2285
taaattatatggtcgttccqcaaaaatgtagccaaggtgaaggaagttatgagggtCctC 7140
C P K E I C S C 0 1 K K 0 K K Q P 0 A 0 2305
taggccctaaggaacttgggtcatgtgatctgaagaaagacaagaagcaaccacaggcag 7200
KDFCQKP QVAIC S PCI $EC12325
aoaaagatttctgccaggaaccacagqtggcttatggctctcctggcctgtctCaaggCc 7260
NI AC LAHKK N CDV $ E 2345
tgaattatgcctgtcttgctcacagagaacatggagatgtgtctgaataatagtqtCtCg 7320
taggaaataoagcactgaqatcaacatcgtgttaagttacttgcagttttgaataaagaa 7380
taaaqtttotqqtqcocaqttqactctqaaaaaaaaaaaaaaaaaaaaa 7440
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Fig. 3. Kyte and Doolittle hydrophobicity/hydrophilicity plot analyses. A. Deduced amino acid sequence of full-length mouse c-ros eDNA. B and C. The
analyses of putative signal peptide and transmembrane regions of c-ros, respectively. In both the regions hydrophilicity approached to -—3.5.
(Fig. 4). The highest dilution of competitive plasmid DNA with
detectable amplified product was chosen to represent the c-ros
expression during the later stages of development. At this dilu-
tion, the ratio was 10. The c-ros expression was decreased
remarkably by day 17 (Fig. 5). During the neonatal period
(post-conception day 21), the ratio reflecting the c-ros expression,
initially increased 50%, but by day 41 the ratio decreased
dramatically to one hundredth the level at day 13. The ratio for
-actin remained constant, that is, 10, throughout the gesta-
tional and neonatal periods (Fig. 5).
Role of c-ros in metanephric development
Since the expression studies suggested a temporal regulation
c-ros, attempts were made to elucidate the role of c-ros in
metanephric development using nonsense- antisense-deoxyoligo-
nucleotides (ODNs), the specificities of which were established by
S1 nuclease protection assays (Fig. 6).
Total RNA was extracted from embryonic kidneys exposed to
sense, nonsense and antisense, and cDNAs were prepared. In-
tially, non-competitive PCR analyses of the eDNA revealed a
dose-dependent decrease in the amplification product with the
exposure of antisense ODN (0 to 1.0 /.LM). Further competitive
PCR analyses were carried out at a concentration of 0.5 M of
antisense-ODN. The same amounts of total RNA, isolated from
control (nonsense-ODN) and antisense-exposed ODNs, were
used to prepare the cDNAs, and the analyses were carried out as
described above. The antisense-ODN exposure caused a reduc-
tion in the c-ros mRNA, as reflected by the decreased incorpora-
tion of [cs32P]dCTP during first-strand cDNA synthesis using c-ros
antisense-ODN as a primer. The decreased incorporation was
ascertained by electrophoresis of the de novo synthesized c-ros-
specfic eDNA on alkaline agarose gels, followed by autoradiogra-
phy and densitometric analyses. Also, a reduction of c-ros expres-
sion was observed by competitive RT-PCR analyses, in which a
constant amount of oligo(dt)-primed eDNA with serial dilutions
of competitive plasmid DNA were co-amplified (Fig. 7). The
amplified c-ros eDNA PCR product were barely detectable even
when the lowest concentration (108) of the competitive plasmid
DNA was employed (Fig. 7). However, no significant decrease of
the f3-actin eDNA was observed in kidneys exposed to antisense-
ODN versus sense or nonsense-ODN (Fig. 10, lanes 7 and 8).
The in situ hybridization studies revealed that the c-ros mRNA
was expressed on the ureteric bud branches and their tips and in
developing glomerular bodies in the embryonic kidneys (Fig. 8A).
The highest expression was observed on day 13 (Fig. 8A). It
progressively decreased during later stages of gestation, and was
minimally expressed in the neonatal period. The antisense-ODN
treatment of metanephric explants in culture caused a notable
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Fig. 4. Competitive RT-PCR of c-ros cDNA prepared from mouse embty-
onic kidneys, harvested at 13th day of the gestation. Fixed amount of first
strand cDNA and logarithmic dilutions of the competitive plasmid DNA
are used as templates for the amplification of the PCR products. The
amplified products exhibit linearity between the logarithmic dilutions
(10—' to 10—6, lanes 1—6) of competitive plasmid DNA and the ratio of
amplified c-ros cDNA (upper bands) to plasmid DNA (lower bands). Lane
M represents the molecular weight markers.
Fig. 5. Competitive RT-PCR of c-ros and p-actin cDNAs prepared from
mouse kidneys, harvested at various stages of gestation and post-natal period.
Fixed amount of first strand cDNA and competitive plasmid DNA are
used as templates for the amplification of the PCR products. The ratio of
c-ros eDNA to competitive plasmid DNA (—) decreases during the later
stages of gestation and post-natal period (left panel, lanes 1—4); while the
ratio of 13-actin cDNA to competive plasmid DNA (- -) remains constant
(right panel, lanes 5—8). Lane M represents the molecular weight markers.
Lanes I and 5, 2 and 6, 3 and 7, 4 and 8 represent mRNA isolated from
13, 17, 21 and 41 days following conception, respectively.
depletion of c-ros mRNA expression on the ureteric bud branches
and their tips (Fig. 8B), suggesting a potential role of c-ros in the
morphogenesis of the kidney.
The morphological changes induced by the antisense-ODN (0.5
I.LM) treatment included disorganization of ureteric bud branches,
1 23 4
Fig. 6. Autoradiograms of S1 nuclease digests of antisense-ODN:RNA hy-
brids. Lanes 1 and 3 represent 5 g of metanephric kidney mRNA
hybridized with antisense-ODN at 40°C and 45°C, respectively; followed
by S, nuclease digestion. A single band of radioactivity, corresponding to
the size of ODN (— 29 mer) is observed in both the lanes. No band is seen
in the control mRNA samples (lanes 2, 4) incubated with nonsense-ODN,
indicating the susceptibility of the unprotected radiolabeled ODN to S,
nuclease digestion.
Fig. 7. Competitive RT-PCR of c-ros cDNAs prepared from control (•, C,
lanes 1 to 4) and antisese-ODN-treated ('O, A, lanes 5 to 8) kidney explants
in metanephric culture. A reduction in the amplification of the PCR
products is observed in cDNAs prepared from antisense-treatcd kidneys.
The amplified PCR product is barely detecable even at the highest dilution
(10) of the competitive plasmid DNA. While in the control, the
amplified PCR product can be detected at the highest concentration
(10') of competitive plasmid DNA.
mild blunting of their tips, and a significant reduction of develop-
ing tubular and glomerular elements (Fig. 9 B vs. A). No significant
reduction in the overall size of the kidneys was observed. Some of the
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Fig. 8. Darkfield light-microscopic in situ hybridization autoradiograms of
the control (A) and c-ros-antisense-ODN-treated (B) metanephric explants.
The tissue sections are hybridized with [35SIdATP-labeled c-ros anti-
sense-ODN. A: The c-ros is normally expressed on the ureteric bud
branches (U) and the developing glomeruli (G). B: c-ros expression is
completely lost in the antisense-treated kidneys. X 25.
ureteric bud branches were seen as hollow tubular structures. Be-
sides the ureteric bud branches, most of the metanephric tissue was
made up of loose mesenchyme with sparsely populated nephron
elements; however, no discernible cytotoxic effects were observed.
The exposure of nietanephric explants with sense or nonsense or
antisense + nonsense-ODNs caused minimal changes in the renal
morphology and population of nephric elements (Fig. 9 C vs. A).
Expression of extracellular matris (ECM) glycoproteins
The above fIndings suggest that c-ros is expressed at the tips of
ureteric bud branches, and may be relevant to the formation of
nephric elements. The ECM proteins are also highly expressed at
the epithelial-mesenchymal interface [35], and are believed to
play a role in metanephric development. In view of these consid-
erations, the status of ECM proteins was investigated under
conditions of reduced c-ros mRNA expression. Thus, metanephric
explants exposed to c-ros antisense-ODN (0.5 JxM) were radiola-
beled either with [35S]-methionine or [35S]-sulfate and then
assessed by immunopreciptation and tissue autoradiographic
studies.
Competitive RT-PCR analyses for some of the major ECM
glycoproteins, that is, perlecan (proteoglycans), laminin and
type-TV collagen were carried out as described above. With the
translational blockade of c-ros, a tenfold decrease in the ratio of
heparan sulfate-proteoglycan (perlecan) eDNA to competitive
plasmid DNA was observed (Fig. 10, lanes I and 2). The ratio for
laminin expression decreased by half (Fig. 10, lanes 3 and 4), while
no significant change in the expression of type-TV collagen (Fig.
Fig. 9. Photomicrographs of the untreated (A), antisense-ODN (B) and
nonsense-ODN-treated (C) metanephric explants. The antisense-ODN-
treated kidney shows dysmorphogenesis of the ureteric bud branches (U),
and a reduced population of glomerular and tubular elements in the loose
uninduced metanephric mesenchyme. x 35.
H6-PG Laminin Collagen
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4-
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Fig. 10. Gene expression of various ECM glycoproteins, analyzed by quan-
titative RT-PCR. Lanes 1, 3, 5 and 7 () represent amplified PCR products
of cDNAs prepared from control explants. Lanes 2, 4, 6 and 8 (El)
represent amplified PCR products of cDNAs prepared from antisense-
treated explants. A marked reduction in the perlecan (lanes I and 2) gene
expression is observed in metanephric explants treated with c-ros anti-
sense-ODN. A mild reduction is seen in the laminin (lanes 3 and 4)
expression as well. No significant change in expressions of type-TV
collagen (lanes 5 and 6) and 13-actin (lanes 7 and 8) are observed. The
bar-graph data reflect the mean and standard error of 5 different
experiments.
10, lanes 5 and 6) or J3-actin (Fig. 10, lanes 7 and 8) was observed.
Comparable changes were observed in the expression of ECM
glycoproteins (Fig. 11). A marked reduction in the heparan
sulfate-proteoglycan (HS-PG) was observed. The laminin expres-
sion was reduced moderately, while that of type-TV collagen was
unchanged (Fig. 11).
Light microscopic tissue autoradiography of the explants re-
vealed a generalized reduction in the [35S]-sulfate incorporation,
as reflected by the decreased concentration of silver grains over
the metanephric explants (Fig. 12 B vs. A). This suggested a
decrease in the de novo synthesis of proteoglycans (PGs) since
most of [35S]-.sulfate radioactivity has been found to be associated
with sulfated PGs [36, 37]. The decrease in the autoradiographic
grains was particularly noticeable at the epithelial-mesenchymal
interface where PGs are heavily expressed (Fig. 12A). The spatial
distribution of sulfated PGs was further confirmed by electron
microscopic tissue autoradiography (Fig. 13). Normally, a heavy
concentration of autotradiographic grains is observed at the
epithelial-mesenchymal interface (Fig. 13B). With the treatment
of c-ros antisense-ODN, a notable reduction of the silver grains is
observed at the interface (Fig. 12 A vs. B). In addition to the
decrease of autoradiographic grains, the interface region between
the mesenchymal and uretcral epithelial cells was notably reduced
(Fig. 13 A vs. B). In contrast to ['S1-sulfate, the [35S]-mcthionine
incorporation into the de novo synthesized proteins was minimally
decreased in the metanephric explants exposed to antisense-ODN
(Fig. 12 D vs. C), suggesting that the translational blockade had
selectively affected the gene expression and de novo synthesis of
sulfated PGs versus other glycoproteins.
Discussion
The results of this investigation suggest that c-ros is expressed in
the kidney, and the nucleotide sequence analyses of various clones
Fig. 11. Radioactivity per mg of protein of [35S1-methionine-labeled glyco-
proteins immunoprecipitated by specific antibodies after the 7 days of ex-
posure of c-ros antisense-ODN to metanephric explants. Symbols are: ()
control; (El) antisense. Incorporated radioactivity immunoprecipitated by
anti-HS-PG antibody is remarkably decreased with the treatment of
antisense-ODN, while mild reductions are seen in radioactivity immuno-
precipitated by laminin and type-TV collagen antibodies. The insets show
the corresponding autoradiograms, and the arrows indicate the loca-
tions of the bands of various ECM glycoproteins as previously de-
scribed [21, 37].
indicate that there are no splice variants present in the mouse
kidney. The expression is highest at the 13th day of gestation, and
is concentrated on the tips of ureteric bud branches. The in situ
hybridization and antisense experiments suggest that, like ECM
glycoproteins, the c-ros is highly expressed at the tips of ureterie
bud branches and, thus, may be involved in the epithelial-
mesenchymal interactions necessary for the organogenesis of the
kidney.
The mouse c-ros renal eDNA, like that of human, rat and
chicken [18, 31, 32], had a typical extracellular, transmembrane
and an intracellular domain with a catalytic tyrosine kinase
segment (Fig. 1). Among the various avian and mammalian
species, the mouse c-ros had the highest nucleotide sequence
homology with that of the rat, — 91% [31]. The mouse c-ros pro-
tein product seems to be somewhat larger, with additional amino
acid residues, than that of the rat (2340 vs. 2317) and chicken
(2340 vs. 2311) kidney cDNAs [31, 321. Unlike rat lung c-ros
eDNA [311, it neither contained any splice variants nor insertional
sequences nor lacked any phosphorylation sites. Thus, being
similar to that of the rat c-ros kidney eDNA and containing an
intracellular kinase domain, it, most likely, has relevance in some
renal biological processes. Needless to say, it seems that a
thorough characterization of its ligand is warranted in order to
precisely delineate its biological functions in various tissues [29,
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Fig. 12. Light microscopic autoradiograms of 7-day nonsense- (A and C)
and c-ros antisense-ODN-treated (B and D) embiyonic kidneys labeled either
with [35S]-sulfate (A and B) or [35S]-methionine (C and D) in metanephric
culture system. A marked reduction in radioactivity is observed over the
tips of ureteric bud branches (U) in the antisense-treated explants labeled
with 35S]-sulfate (B vs. A), while no significant changes are seen in the
[35S]-methionine labeled metanephroi (D vs. C). Arrowheads indicate the
developing glomerular elements. A and B, X 150; C and D, X75.
301. The c-ros may function as a receptor similar to the tyrosine
kinase receptors for growth factors. However, it is interesting to
note that, unlike mouse insulin or insulin like growth factor
(IGF-I) receptors [21], the c-ros is devoid of cysteine clusters in its
extracellular domain (Fig. 2), which may play some role in the
ligand-receptor interactions. In any event, the contents of cysteine
residues and N-linked glycosylation sites were increased in the
mouse relative to rat c-ros renal cDNA (Fig. 2). The presence of
numerous glycosylation sites (— 32) in the extracellular domain
would suggest its conceivable interactions with the ligand to be
potentially very complex.
The intracellular domain had three potential tyrosine phos-
phorylation sites, similar to the rat. However, the 3' noncoding
region was much smaller compared to the rat and chicken c-ros
renal cDNAs [31, 32], but had multiple (— 3) polyadenylation
(AATAAA) signal sites. Unlike chicken c-ros, it had no A(U)A
Fig. 13. Electron microscopy autoradiograms of 7-day c-ros antisense- (A)
and nonsense-ODN-treated (B) embiyonic kidney esplants labeled with
[35S1-sulfate. The explant treated with the antisense-ODN shows a marked
decrease of autoradiographic grains at the interface (I) between the
mesenchymal (Me) and epithelial (Ep) cells of the ureteric bud branches
compared with the control embiyonic kidney. x40,000.
mRNA instability motifs which are possibly involved in its post-
transcriptional regulation. Because of the lack of instability mo-
tifs, both in mouse and rat, c-ros expression can be maintained at
constant and relatively high level in the mammalian fetal kidneys
essential for the embryonic development. The c-ros cytoplasmic
domain did not contain SH2 and SH3 (src homology) regions
which are present in other receptors of the tyrosine kinase family;
yet, conceivably, it is functional since it shares certain structural
features common to sevenless, insulin and IGF-I receptor gene
products, such as the presence of multiple tyrosine amino
En
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acid residues and a defined length of the spacer between the
tyrosine protein kinase and transmembrane domains [19, 20, 32].
The transmembrane domain of mouse c-ros renal cDNA had a
hydrophobicity approaching almost 3.5 (Fig. 3), and was higher
than that observed in the avian species [32]. Also, hydrophobicity
for the putative signal peptide segment was increased. The
increased hydrophobicity of these domains in mammalian species
may reflect a high degree of flexibility mobility of c-ros within lipid
bilayer, which may further facilitate ligand-receptor and cell-cell
interactions during various developmental processes.
The developmental expression of c-ros was investigated by
RT-PCR methods since sufficient amount of mRNA cannot be
isolated from embtyonic kidneys for Northern blot analyses. After
establishing the optimal conditions for the competitive RT-PCR
(Fig. 4), the c-ros expression was determined during the fetal,
neonatal and post-natal periods of renal development (Fig. 5).
The highest levels were observed at the 13th day of gestation, the
time at which maximal epithelial-mesenchymal interactions occur.
At this stage of development, the receptor concentrations for
other growth factors, for example, IGF-IR [21], are also high,
suggesting that the c-ros biological effects are probably similar to
the other known tyrosine kinase receptors involved in organogen-
esis. Since sevenless gene product, a member of the tyrosine kinase
receptor family, plays a major role in the organogenesis of the
compound eye in Drosophila [33]; a role of c-ros in renal devel-
opment would be expected. Also, it is interesting to note that, like
other growth factor receptors with tyrosine kinase domains [19—
25], the c-ros expression also declines during the latter half of
gestation, suggesting that its role is restricted to embryonic period,
and that it has less significance during the later stages of devel-
opment and the neonatal period.
The role of c-ros in renal development was ascertained by
perturbing its gene activity with antisense-ODNs. The specificity
of the ODNs were confirmed by subjecting RNA:DNA hybrids to
S nuclease digestion (Fig. 6), as described previously [21, 37, 47].
Also, the specificity of ODNs was maintained by using them at a
relatively low concentration (0.5 jIM) in in vitro culture conditions.
Usually, the antisense and sense ODNs have nonspecific transla-
tional inhibitory effects when used above a concentration of 1 jIM
in the medium [48]. Moreover, at a higher concentration (> 2.5
jIM) they may cytotoxic [49]. However, at a relatively low concen-
tration (< 0.25 jIM) any discernable antisense-ODN effects on the
target organ system in vitro may not be observed, since they are
readily susceptible to nuclease degradation. The latter difficulty
can be overcome by employing phosphorothioated ODNs which
are resistant to nuclease degradation. Finally, the specificity of the
probes, both nonsense and antisense ODNs need to be throughly
examined by homology searches (FASTA program) with known
nucleotide sequences avialable in the gene bank. The effects
would be regarded as nonspecific if a given ODN had more than
60% homology with the nucleotide sequences of unrelated genes.
Moreover, under these conditions, primer specificity would be
quite low, and it may be virtually impossible to find suitable
conditions to carry out competitive-RT-PCR analyses. Applica-
tion of the above considerations in designing the protocol of this
investigation yielded successful results in the competitive RT-
PCR studies employed in the antisense experiments. The anti-
sense experiments revealed that the c-ros specific cDNA expres-
sion was barely detectable (Fig. 7), even at the highest dilution of
competitive plasmid DNA (10), suggesting that the c-ros
mRNA levels has indeed been reduced. The reduced c-ros mRNA
expression was further confirmed by in situ hybridization studies,
in which there was absence of message on the urteric bud
branches (Fig. 8). With such a decreased gene activity, evidenced
by absence of c-ros message on the epithelial component of the
metanephroi, certain structural alterations in the urteric bud
branches would be anticipated. Indeed, canalization of the ure-
teric bud branches and blunting of their tips were observed (Fig.
9). The blunting of the tips have been reported to be responsible
for perturbed epithelial-mesenchymal interactions leading to a
decrease in the population of the nephric elements [50]. Such a
reduction was quite evident in the present studies as well (Fig. 9),
which affirms the relevance of c-ros in heterotypic cell-cell inter-
actions. Here, one may envision that the presence of c-ros in the
ureteric bud and developing nephric epithelia, and that of its
ligand in the mesenchyme would be conducive for the epithelial-
mesenchymal interactions to proceed normally in the maturation
of metanephros.
Such heterotypic interactions are also believed to be occur
during the biological activities of other proto-oncogenes, such as
Pax-2 [51] and c-met [23]. The Pax-2 and c-met are expressed in
the ureteric bud epithelia while their putative ligands are conceiv-
ably present in the uninduced metanephric mesenchyme. Such a
strategic spatio-temporal distribution of ligands and receptors are
conducive to cell-cell interactions necessary for renal organogen-
esis. In fact, the role of these proto-oncogenes in metanephric
development has been elegantly elucidated by antisense experi-
ments [51]. Inclusion of Pax-2 antisense-ODN into the in vitro
metanephric culture medium resulted in the failure of aggregation
of mesenchymal cells and their conversion into epithelial nephric
elements. In such a scenario of cell-cell interactions, the other
gene products relevant to the renal development may include
Wnt-4 and hedgehog (hh) [52, 53]. The Wnt-4 is expressed in the
metanephric mesenchyme, while hh is believed to be present in
the epithelial components of the kidney, suggesting that such a
distribution is ideally suited for epithelial-mesenchymal interac-
tions. In fact, the gene products of WnT-4 and hh have been shown
to exert a morphogenetic influence in cellular patterning of
Drosophila and in the inductive conversion of mesenchymal cells
into well-differentiated mammalian renal glomerular and tubular
epithelia [52, 53].
The inference from the above discussion is that the interface,
between the ureteric epithelium and uninduced mesenchyme, is
the region critical for the development of the kidney and gener-
ation of functional nephrons. Naturally, the macromolecules
present at the interphase would be of considerable interest with
respect to metanephric development. In the early sixties and
seventies, such macromolecules, pertinent to epithelial-mesenchy-
mal interactions, were identified in other systems, such as salivary
glands, and they include ECM glycoproteins, in particular, the
proteoglycans (PGs) [54, 55]. Subsequently, the role of ECM
glycoproteins in the morphogenesis of the kidney was elucidated
[36]. Their perturbed synthesis has been correlated with dysmor-
phogenesis of the metanephroi [36], while increased expression
has been associated with renal hypertrophy, induced by certain
growth factors [37]. Along these lines, in this study, antisense-c-
ros-induced dysmorphogenesis was found to be associated with
the decreased gene expression and de novo synthesis of ECM
glycoproteins (Figs. 10 and 11). Among the ECM glycoproteins,
the major alteration was confined to the proteoglycans (POs). As
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previously reported [36, 371, normally an accentuated synthesis of
PGs is observed at the interface, as reflected by the [35S]-sulfate
incorporation at this site in tissue autoradiographic studies (Figs.
12A and 13B). The decreased concentration of radioactivity at
this crucial site (Figs. 12B and 13A) supports the notion that the
antisense-c-ros-induced dysmorphogenetic changes are related to
the altered expression of the PGs. This selective altered synthesis
may be due to faster turnover of PGs as compared to the other
ECM glycoproteins, thus rendering them susceptible to biochem-
ical injury induced by various agents. A mild reduction in synthesis
and expression of laminin was also observed. However, overall
protein synthesis was not significantly affected, as no discernible
change in the [35SJ-methionine incorporation was observed in
tissue autoradiographic studies (Fig. 12A vs. 13B). This suggests
that ECM proteoglycans, the established morphogenetic regula-
tors [56], were selectively affected by the reduced c-ros gene
activity. Incidentally, the PGs also serve as reservoirs for some
growth factors [57]. Thus, an altered expression of PGs may lead
to a decreased local concentration of ECM-bound growth factors,
and thereby contribute to the perturbed morphogenesis of the
murine embryonic kidney.
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